Hyewon Woo
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Exploring the Impact of RNU4-2 Defects on Neurodevelopmental Disorders in a Korean Population.
Journal: Clinical genetics
Published: September 23, 2025
Long-term outcome in children with infantile epileptic spasms syndrome: a multicenter retrospective study in Korea.
Journal: Clinical and experimental pediatrics
Published: September 08, 2025
Screen time and neurodevelopment in preschoolers: addressing a growing concern in pediatric practice.
Journal: Clinical and experimental pediatrics
Published: October 13, 2024
Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020).
Journal: Children (Basel, Switzerland)
Published: April 09, 2024
Autosomal dominant HK1-related neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA): An emerging mitochondrial disorder.
Journal: Genetics in medicine open
Published: April 06, 2024
Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy.
Journal: Epilepsy & behavior : E&B
Published: November 29, 2023
Exploring the Clinical Utility of Targeted MECP2 Testing in Real-World Practice.
Journal: Pediatric neurology
Published: November 29, 2023
Adolescent-Onset Epilepsy: Clinical Features and Predictive Factors for First-Year Seizure Freedom.
Journal: Neuropediatrics
Published: November 23, 2023
Clinical Profile and Predictors of Recurrent Simple Febrile Seizure.
Journal: Pediatric neurology
Published: September 18, 2023
The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure.
Journal: Orphanet journal of rare diseases
Published: May 26, 2022
Seizure Evolution and Outcome in Pediatric Autoimmune Encephalitis.
Journal: Pediatric neurology
Published: April 19, 2022
Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy.
Journal: Brain & development
Published: November 02, 2021
Last Updated: 09/26/2026